Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,617Revenue $M580Net Margin (%)-11.0Altman Z-Score1.6
Enterprise Value $M2,722EPS $-1.0Operating Margin %-23.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)-14.6Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %--Current Ratio3.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-153.2ROA % (ttm)-3.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-6.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M66.8ROIC % (ttm)-11.9Gross Margin Increase y-yY

Gurus Latest Trades with MDCO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDCOVanguard Health Care Fund 2015-03-31 Add0.01%$24.32 - $31.29
($28.09)
$ 39.4040%Add 1.88%5,564,220
MDCOVanguard Health Care Fund 2014-12-31 Add0.04%$20.36 - $27.96
($24.81)
$ 39.4059%Add 14.67%5,461,430
MDCOJoel Greenblatt 2014-12-31 Sold Out -0.01%$20.36 - $27.96
($24.83)
$ 39.4059%Sold Out0
MDCOJoel Greenblatt 2014-09-30 Reduce-0.06%$22.95 - $29.64
($25.38)
$ 39.4055%Reduce 87.68%24,009
MDCOGeorge Soros 2014-09-30 Sold Out -0.02%$22.95 - $29.64
($25.38)
$ 39.4055%Sold Out0
MDCOVanguard Health Care Fund 2014-09-30 Add$22.32 - $29.64
($25.4)
$ 39.4055%Add 1.33%4,762,730
MDCOJoel Greenblatt 2014-06-30 Buy 0.07%$24.02 - $29.57
($26.67)
$ 39.4048%New holding194,954
MDCOGeorge Soros 2014-06-30 Buy 0.02%$24.02 - $29.57
($26.67)
$ 39.4048%New holding75,000
MDCOGeorge Soros 2014-03-31 Sold Out -0.02%$27.9 - $40.39
($33.35)
$ 39.4018%Sold Out0
MDCOVanguard Health Care Fund 2014-03-31 Add0.01%$27.9 - $40.39
($33.09)
$ 39.4019%Add 2.20%4,700,058
MDCOJoel Greenblatt 2014-03-31 Sold Out -0.01%$27.9 - $40.39
($33.35)
$ 39.4018%Sold Out0
MDCOGeorge Soros 2013-12-31 Reduce-0.07%$31.48 - $38.91
($35.74)
$ 39.4010%Reduce 80.00%50,000
MDCOVanguard Health Care Fund 2013-12-31 Add0.04%$31.48 - $38.91
($35.78)
$ 39.4010%Add 8.20%4,599,069
MDCOJoel Greenblatt 2013-12-31 Buy 0.01%$31.48 - $38.91
($35.74)
$ 39.4010%New holding13,990
MDCOVanguard Health Care Fund 2013-09-30 Add0.33%$29.68 - $34.54
($31.83)
$ 39.4024%Add 219.22%4,250,415
MDCOGeorge Soros 2013-09-30 Add0.04%$29.68 - $34.54
($31.83)
$ 39.4024%Add 66.67%250,000
MDCOVanguard Health Care Fund 2013-06-30 Add0.1%$30.76 - $37.1
($33.46)
$ 39.4018%Add 181.56%1,331,500
MDCOGeorge Soros 2013-06-30 Add0.02%$30.76 - $37.1
($33.46)
$ 39.4018%Add 57.89%150,000
MDCOVanguard Health Care Fund 2013-03-31 Buy 0.06%$23.97 - $33.41
($30.53)
$ 39.4029%New holding472,900
MDCOGeorge Soros 2013-03-31 Buy 0.04%$23.97 - $33.41
($30.53)
$ 39.4029%New holding95,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDCO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MDCO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MEANWELL CLIVEChairman & CEO 2015-08-03Sell16,667$30.9627.26view
MEANWELL CLIVEChairman & CEO 2015-07-01Sell16,667$28.3938.78view
SBLENDORIO GLENNPresident & CFO 2015-06-25Sell3,305$3223.13view
Shigeta HiroakiDirector 2015-06-08Sell7,500$28.9935.91view
MEANWELL CLIVEChairman & CEO 2015-06-01Sell16,667$28.1140.16view
Savage Robert G.Director 2015-05-20Sell15,000$26.7847.12view
WYATT ELIZABETH H SDirector 2015-05-19Sell15,000$26.847.01view
CROUSE WILLIAMDirector 2015-05-19Sell15,000$26.8646.69view
KESSLER ARMIN MDirector 2015-05-13Sell12,475$25.8752.3view
MEANWELL CLIVEChairman & CEO 2015-05-01Sell16,667$26.5248.57view

Quarterly/Annual Reports about MDCO:

News about MDCO:

Articles On GuruFocus.com
Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, Medicines Co Cangrelor Well-Recomm Apr 16 2015 
Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner Apr 25 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
George Soros' Top Buys in the Last Quarter Dec 23 2011 
George Soros Buys Amazon.com Inc., Motorola Solutions, Sandisk, Sells Ralph Lauren, Dendreon, Lawson Nov 15 2011 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 100,000 Shares Mar 01 2011 
Medicines Company Reports Operating Results (10-Q) Nov 09 2010 
Medicines Company Reports Operating Results (10-Q) May 10 2010 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 181,500 Shares May 04 2010 

More From Other Websites
The Medicines Company (MDCO) and Alnylam Pharmaceuticals Inc. (ALNY)’s Positive Phase I Results... Aug 31 2015
Medicines Shares Surge on Cholesterol-Drug Data Aug 31 2015
The Medicines Company and Alnylam Rise on Positive Phase 1 Results Aug 31 2015
The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board Aug 31 2015
Medicines shares surge on upbeat cholesterol drug study Aug 31 2015
Medicines shares surge on upbeat cholesterol drug study Aug 31 2015
MEDICINES CO /DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale... Aug 31 2015
The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board Aug 31 2015
7:29 am The Medicines Co up ~20% premarket following positive ongoing Phase 1 clinical trial with... Aug 31 2015
Cholesterol-fighting 'game changer': Alnylam CEO Aug 31 2015
​Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's Aug 30 2015
ALN-PCSsc Achieves Quarterly and Potentially Bi-Annual Subcutaneous Dose Regimen Profile for... Aug 30 2015
Alnylam, Medicines cholesterol drug lasts months after one shot Aug 30 2015
Alnylam, Medicines cholesterol drug lasts months after one shot Aug 30 2015
ALN-PCSsc Achieves Quarterly and Potentially Bi-Annual Subcutaneous Dose Regimen Profile for... Aug 30 2015
ALN-PCSsc Achieves Quarterly and Potentially Bi-Annual Subcutaneous Dose Regimen Profile for... Aug 30 2015
Alnylam, Medicines Co. Cholesterol Shot Exceeds Expectations, Lasts 140 Days Aug 30 2015
ALN-PCSsc Achieves Quarterly and Potentially Bi-Annual Subcutaneous Dose Regimen Profile for... Aug 30 2015
The Medicines Co upgraded by Jefferies Aug 28 2015
Here's One Biotech Stock JMP Analysts Are Very Bullish On Aug 26 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK